Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways

13 Oct 2021

Abstract excerpt

INTRODUCTION: Vaccines are the agreed upon weapon against the COVID-19 pandemic. This review discusses about COVID-19 subunit vaccines adjuvants and their signaling pathways, which could provide a glimpse into the selection of appropriate adjuvants for prospective vaccine development studies. AREAS COVERED: In the introduction, a brief background about the SARS-CoV-2 pandemic, the vaccine development race and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diverse Scientific Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34633259
DOI: 10.1080/14760584.2021.1991794

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 subunit vaccine adjuvants and their signaling pathwaysPMID 34633259Read ↗

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read ↗

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read ↗

Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics frameworkSemantic proximity Read ↗

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read ↗

Engineering a Multi Epitope Vaccine Against SARS-CoV-2 By Exploiting Its Non Structural and Structural ProteinsSemantic proximity Read ↗

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read ↗

An Overview of Vaccine Development for COVID-19Semantic proximity Read ↗

An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccineSemantic proximity Read ↗

The vaccines can keep up with the SARS-CoV-2 mutations.Semantic proximity Read ↗

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read ↗

Bioinformatics Designing and Molecular Modelling of a Universal mRNA Vaccine for SARS-CoV-2 InfectionSemantic proximity Read ↗

Vaccine efficacy against COVID-19: A foresight on the host-associated factorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.